AI summary
A plain-English summary drawn only from this filing: what it is, why it matters, and the parties, amounts and dates it turns on.
What we verified from this filing67 verified
- financial positionnote: The list totals $6,696,626 (all rows expressed in CAD after conversion). Largest claims: Lotus Clinical Research $3,737,737; Patheon (Thermo Fisher) $1,181,567; Lonza Bend $544,246. No asset values appear in this document. · page: 1 · as at: 2024-04-09 · basis: CCAA s.23(1)(a) List of Creditors, claims over $1,000, as at April 9, 2024; USD converted at 1.35. · scope: Antibe Therapeutics Inc. — claims of $1,000 or less are excluded by the list's own threshold; the list has no secured section. · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 22600 · debtor: Antibe Therapeutics Inc. · creditor: 14130855 Canada (Wallace, John) · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 3396 · debtor: Antibe Therapeutics Inc. · creditor: Allele Capital Partners · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 6791 · debtor: Antibe Therapeutics Inc. · creditor: Allele Communications · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 50973 · debtor: Antibe Therapeutics Inc. · creditor: Axiom Real-Time Metrics · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 19791 · debtor: Antibe Therapeutics Inc. · creditor: BCS Statistical Solutions · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1157 · debtor: Antibe Therapeutics Inc. · creditor: Bell Canada · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1752 · debtor: Antibe Therapeutics Inc. · creditor: Bhito Integrated Solutions · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 33900 · debtor: Antibe Therapeutics Inc. · creditor: Bloom Burton Securities Inc. · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 21656 · debtor: Antibe Therapeutics Inc. · creditor: BND Projects · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 5933 · debtor: Antibe Therapeutics Inc. · creditor: Business Wire · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 4755 · debtor: Antibe Therapeutics Inc. · creditor: Caligor Opco LLC (CalCog) · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 11300 · debtor: Antibe Therapeutics Inc. · creditor: CDM Canada Ltd. · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 10399 · debtor: Antibe Therapeutics Inc. · creditor: Charles River CANADA · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 8426 · debtor: Antibe Therapeutics Inc. · creditor: Computershare · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Corealis Pharma · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: CSC · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Deloitte Restructuring · currency: CAD
- unsecured creditorsnote: Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 2958 · debtor: Antibe Therapeutics Inc. · creditor: Digby, Thomas J. · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 49705 · debtor: Antibe Therapeutics Inc. · creditor: DILIsym Services · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. Aggregate row for the company's directors; no individuals are named. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Directors · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 20325 · debtor: Antibe Therapeutics Inc. · creditor: DLA Piper · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 10819 · debtor: Antibe Therapeutics Inc. · creditor: EKS Business Development · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 14634 · debtor: Antibe Therapeutics Inc. · creditor: Elegen Group · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. Aggregate employee row; no individuals are named. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Employees · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 171280 · debtor: Antibe Therapeutics Inc. · creditor: Ernst & Young · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 13560 · debtor: Antibe Therapeutics Inc. · creditor: FG Pharma · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 19026 · debtor: Antibe Therapeutics Inc. · creditor: Fifteen Prince Arthur · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. Foreign state claim. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Florida Division of Taxation · currency: CAD
- unsecured creditorsnote: Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 2716 · debtor: Antibe Therapeutics Inc. · creditor: Forney, Mark · currency: CAD
- unsecured creditorsnote: Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 16097 · debtor: Antibe Therapeutics Inc. · creditor: Garland, Anthony · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Gowling WLG · currency: CAD
- unsecured creditorsnote: Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 2500 · debtor: Antibe Therapeutics Inc. · creditor: Haut, Donald · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 10000 · debtor: Antibe Therapeutics Inc. · creditor: Independent Trading Group · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 13673 · debtor: Antibe Therapeutics Inc. · creditor: Innomar Strategies · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. Foreign state claim (United States Internal Revenue Service). · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: IRS · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 15255 · debtor: Antibe Therapeutics Inc. · creditor: Klick Health · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 544246 · debtor: Antibe Therapeutics Inc. · creditor: Lonza Bend · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 53575 · debtor: Antibe Therapeutics Inc. · creditor: Lonza Nansha · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 20555 · debtor: Antibe Therapeutics Inc. · creditor: Lonza Tampa · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 3737737 · debtor: Antibe Therapeutics Inc. · creditor: Lotus Clinical Research · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. Crown claim (Ontario). · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Minister of Finance - ON · currency: CAD
- unsecured creditorsnote: Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 6000 · debtor: Antibe Therapeutics Inc. · creditor: Monnet, Dominique P. · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 28515 · debtor: Antibe Therapeutics Inc. · creditor: National Institute of Oncology (Budapest) · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 50937 · debtor: Antibe Therapeutics Inc. · creditor: Nucro-Technics · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1664 · debtor: Antibe Therapeutics Inc. · creditor: R. P. Chiacchierini Consulting · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. Foreign state claim (spelled “Oklohoma” on the list). · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Oklohoma Division of Taxation · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 63020 · debtor: Antibe Therapeutics Inc. · creditor: Paliare Roland · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 7950 · debtor: Antibe Therapeutics Inc. · creditor: Passageways · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1181567 · debtor: Antibe Therapeutics Inc. · creditor: Patheon (Thermo Fisher) · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 80726 · debtor: Antibe Therapeutics Inc. · creditor: Pharma Medica · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: PharmaWrite · currency: CAD
- unsecured creditorsnote: Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 2500 · debtor: Antibe Therapeutics Inc. · creditor: Powell, Andrew · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 146277 · debtor: Antibe Therapeutics Inc. · creditor: ProPharma Group · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. Crown claim. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Receiver General (CRA) · currency: CAD
- unsecured creditorsnote: Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 2500 · debtor: Antibe Therapeutics Inc. · creditor: Russell, Angus · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 2698 · debtor: Antibe Therapeutics Inc. · creditor: Scendea · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Stern, Charlotte · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 8037 · debtor: Antibe Therapeutics Inc. · creditor: Stonehedge Pharma · currency: CAD
- unsecured creditorsnote: The stated amount of $1 is the list's own placeholder for an amount not known at the time, not a measured balance. Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 1 · debtor: Antibe Therapeutics Inc. · creditor: Taylor, Jared · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 20755 · debtor: Antibe Therapeutics Inc. · creditor: Toronto Stock Exchange (TSX) · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 15641 · debtor: Antibe Therapeutics Inc. · creditor: Troutman Pepper · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 14738 · debtor: Antibe Therapeutics Inc. · creditor: Uppsala Monitoring Centre · currency: CAD
- unsecured creditorsnote: Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 33123 · debtor: Antibe Therapeutics Inc. · creditor: Vaughan, David · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 72564 · debtor: Antibe Therapeutics Inc. · creditor: WeirFoulds · currency: CAD
- unsecured creditorsnote: Individual creditor. · page: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 12228 · debtor: Antibe Therapeutics Inc. · creditor: Wu, Christopher · currency: CAD
- unsecured creditorspage: 1 · as of: 2024-04-09 · basis: List of Creditors provided pursuant to s.23(1)(a) CCAA — claims greater than $1,000, prepared from the books and records of Antibe Therapeutics Inc. as at April 9, 2024, without admission as to liability or quantum. US-dollar amounts converted at US$1.00:CAD1.35; unknown amounts carry a $1 placeholder. Stated total $6,696,626; the 66 rows as printed sum to $6,696,627 — a $1 footing difference inside the document (it carries fourteen $1 placeholder rows and displays whole dollars). Both recorded as presented; neither adjusted. · amount: 23683 · debtor: Antibe Therapeutics Inc. · creditor: Summit Analytical · currency: CAD